Orthofix Medical Inc.
Orthofix Medical Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 104 | 120 | 82 | 63 | 66 | 58 | 83 | 30 | 26 | 27 | 33 | 34 | |||||
Restricted Cash Current | 1 | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 5 | - | |||||
Accounts Receivable Net Current | 136 | 138 | 136 | 131 | 130 | 132 | 135 | 125 | 125 | 126 | 128 | 114 | |||||
Inventory Net | 184 | 178 | 172 | 174 | 173 | 174 | 189 | 206 | 210 | 219 | 222 | 222 | |||||
Prepaid Expense And Other Assets Current | 21 | 25 | 24 | 23 | 25 | 24 | 23 | 23 | 22 | 25 | 32 | 24 | |||||
Assets Current | 446 | 462 | 417 | 394 | 396 | 390 | 433 | 386 | 386 | 399 | 420 | 394 | |||||
Property Plant And Equipment Net | 131 | 125 | 129 | 130 | 129 | 131 | 140 | 147 | 154 | 158 | 159 | 153 | |||||
Intangible Assets Net Excluding Goodwill | 66 | 69 | 73 | 76 | 79 | 81 | 99 | 105 | 108 | 113 | 117 | 121 | |||||
Goodwill | 195 | 195 | 195 | 195 | 195 | 195 | 195 | 195 | 195 | 195 | 195 | 195 | |||||
Other Assets Noncurrent | 35 | 35 | 37 | 38 | 38 | 26 | 26 | 35 | 39 | 41 | 33 | 43 | |||||
Assets | 873 | 887 | 851 | 833 | 837 | 823 | 893 | 868 | 882 | 906 | 925 | 906 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 64 | 55 | 58 | 50 | 45 | 45 | 49 | 47 | 50 | 57 | 58 | 53 | |||||
Long Term Debt Current | - | - | 0 | - | - | - | 0 | 6 | 5 | 3 | 1 | - | |||||
Finance Lease Liability Current | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Liabilities Current | 93 | 106 | 111 | 109 | 102 | 98 | 119 | 108 | 100 | 90 | 105 | 99 | |||||
Liabilities Current | 157 | 161 | 170 | 160 | 148 | 144 | 169 | 162 | 156 | 151 | 165 | 153 | |||||
Long Term Debt Noncurrent | 222 | 221 | 157 | 157 | 157 | 157 | 157 | 112 | 113 | 115 | 93 | 70 | |||||
Finance Lease Liability Noncurrent | - | 13 | 17 | 17 | 17 | 18 | 18 | 18 | 18 | 18 | 19 | 19 | |||||
Other Liabilities Noncurrent | 52 | 56 | 56 | 56 | 56 | 46 | 47 | 50 | 49 | 52 | 50 | 49 | |||||
Liabilities | 444 | 451 | 401 | 390 | 379 | 365 | 390 | 342 | 336 | 336 | 327 | 290 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | |||||
Additional Paid In Capital Common Stock | 830 | 820 | 814 | 804 | 797 | 786 | 780 | 770 | 765 | 753 | 746 | 742 | |||||
Retained Earnings Accumulated Deficit | -405 | -389 | -368 | -366 | -343 | -329 | -276 | -247 | -220 | -186 | -150 | -128 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | 0 | 1 | 1 | 1 | -3 | -4 | -1 | -3 | -1 | -1 | -2 | |||||
Stockholders Equity | 429 | 435 | 450 | 442 | 458 | 458 | 503 | 526 | 546 | 570 | 599 | 615 | |||||
Liabilities And Stockholders Equity | 873 | 887 | 851 | 833 | 837 | 823 | 893 | 868 | 882 | 906 | 925 | 906 | |||||
Allowance For Doubtful Accounts Receivable Current | 11 | 9 | 8 | 9 | 9 | 9 | 7 | 8 | 8 | 8 | 7 | 7 | |||||
Common Stock Par Or Stated Value Per Share | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |||||
Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | |||||
Common Stock Shares Issued | 41 | 40 | 40 | 40 | 39 | 39 | 38 | 38 | 38 | 37 | 37 | 37 | |||||
Shares Outstanding | 41 | 40 | 40 | 40 | 39 | 39 | 38 | 38 | 38 | 37 | 37 | 37 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -25.48% | -21.38% | -9.57% | - | - | - | - | - | - | - | - | - |
| 2025 | -6.72% | -8.04% | -6.55% | 21.69% | 16.08% | 29.73% | 8.20% | 2.49% | -10.36% | -8.63% | -0.31% | -5.80% |
| 2024 | -1.15% | -4.54% | 18.86% | 0.00% | -12.16% | -8.94% | 7.19% | -3.79% | 0.71% | -5.03% | -25.59% | -30.67% |
| 2023 | - | - | - | 18.49% | -28.40% | -40.20% | -6.24% | 13.66% | 21.75% | 11.69% | -0.08% | 14.54% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.84 | 2.87 | 2.45 | 2.47 | 2.67 | 2.71 | 2.57 | 2.39 | 2.48 | 2.65 | 2.54 | 2.58 | |||||
| Quick Ratio | 1.53 | 1.61 | 1.30 | 1.23 | 1.34 | 1.33 | 1.31 | 0.97 | 0.99 | 1.03 | 1.00 | 0.97 | |||||
| Working Capital | 289.12M | 300.49M | 246.37M | 234.32M | 247.45M | 246.19M | 264.66M | 224.32M | 230.10M | 248.36M | 255.22M | 241.17M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 1.03 | 1.04 | 0.89 | 0.88 | 0.83 | 0.80 | 0.78 | 0.65 | 0.62 | 0.59 | 0.55 | 0.47 | |||||
| Interest Coverage TTM | -1.88 | -2.52 | -4.66 | -3.33 | -3.33 | -3.52 | -2.86 | -4.76 | -6.23 | -9.14 | -16.12 | -30.24 | |||||
| Debt Ratio | 0.51 | 0.51 | 0.47 | 0.47 | 0.45 | 0.44 | 0.44 | 0.39 | 0.38 | 0.37 | 0.35 | 0.32 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.97 | 0.97 | 0.94 | 0.96 | 0.94 | 0.93 | 0.88 | 0.88 | 0.87 | 0.83 | 1.08 | 0.99 | |||||
| Days Sales Outstanding TTM | 58.13 | 59.62 | 60.02 | 57.03 | 57.50 | 58.41 | 59.99 | 55.61 | 56.21 | 57.37 | 51.56 | 51.81 | |||||
| Receivables Turnover TTM | 6.28 | 6.12 | 6.08 | 6.40 | 6.35 | 6.25 | 6.08 | 6.56 | 6.49 | 6.36 | 7.08 | 7.05 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -1.51 | -1.48 | -2.33 | -3.00 | -3.13 | -3.65 | -3.30 | -3.09 | -3.17 | -3.35 | -4.12 | -3.66 | |||||
| Free Cash Flow Per Share TTM | -0.58 | -0.11 | -0.03 | 0.10 | 0.19 | -0.10 | -0.21 | -1.15 | -1.90 | -2.38 | -2.89 | -2.35 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 71.31% | 70.75% | 68.83% | 68.27% | 67.37% | 67.15% | 68.28% | 68.05% | 67.18% | 66.20% | 65.13% | 65.65% | |||||
| Operating Profit Margin TTM | -4.70% | -5.69% | -9.90% | -11.42% | -11.77% | -12.95% | -10.58% | -11.66% | -12.57% | -14.31% | -18.63% | -19.72% | |||||
| Net Profit Margin TTM | -7.41% | -7.27% | -11.21% | -14.56% | -15.29% | -17.78% | -15.76% | -15.18% | -15.62% | -16.64% | -20.28% | -20.39% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 2.99% | 2.59% | 2.85% | 4.31% | 4.84% | 5.85% | 7.08% | 17.32% | 28.94% | 43.54% | 62.06% | 44.20% | |||||
| Net Income Growth (1Y) | -50.11% | -58.06% | -26.83% | 0.08% | 2.67% | 13.12% | -16.78% | -12.66% | 1.99% | 65.92% | 666.60% | 199.53% | |||||
| EPS Growth (1Y) | -51.82% | -59.37% | -29.54% | -3.14% | -1.18% | 8.94% | -19.84% | -15.47% | -1.38% | 57.10% | 318.55% | 61.56% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -6.06 | -7.73 | -6.51 | -4.89 | -3.56 | -4.47 | -5.28 | -5.05 | -4.18 | -4.33 | -3.27 | -3.51 | |||||
| P/B TTM | 0.87 | 1.07 | 1.33 | 1.32 | 0.96 | 1.39 | 1.32 | 1.14 | 0.92 | 0.96 | 0.83 | 0.78 | |||||
| P/S TTM | 0.45 | 0.56 | 0.73 | 0.71 | 0.54 | 0.79 | 0.83 | 0.77 | 0.65 | 0.72 | 0.66 | 0.72 | |||||
| Market Cap | 373.88M | 463.96M | 600.37M | 582.17M | 440.44M | 639.16M | 665.81M | 601.18M | 504.15M | 548.00M | 495.11M | 479.02M | |||||
| Enterprise Value | 491.66M | 565.13M | 676.57M | 677.35M | 532.67M | 738.86M | 823.73M | 690.34M | 596.52M | 639.96M | 557.07M | 516.05M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -23.90M | -4.42M | -1.28M | 3.84M | 7.69M | -3.94M | -7.95M | -44.40M | -72.15M | -89.66M | -106.01M | -87.61M | |||||
| Net Debt | 117.78M | 101.17M | 76.20M | 95.17M | 92.24M | 99.70M | 157.92M | 89.15M | 92.37M | 91.96M | 61.96M | 37.03M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Orthofix Medical Inc. (OFIX) — SEC Financial Statements & Analysis
Orthofix Medical Inc. (OFIX) is a surgical & medical instruments & apparatus company. Orthofix Medical Inc. trades on Nasdaq as: OFIX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Orthofix Medical Inc. reported a 2.99% year-over-year revenue growth, a Gross Profit Margin of 71.31% (TTM), a Debt-to-Equity ratio of 1.03x, a Price-to-Sales (P/S) ratio of 0.45x (TTM), a Price-to-Book (P/B) ratio of 0.87x (TTM), at a market cap of $373.88M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 2.99%
- Gross Profit Margin TTM
- 71.31%
- Debt To Equity
- 1.03x
- P/S TTM
- 0.45x
- P/B TTM
- 0.87x
- Market Cap
- $373.88M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Orthofix Medical Inc. in?
Orthofix Medical Inc. (OFIX) operates in the Surgical & Medical Instruments & Apparatus industry.
What is OFIX's market cap?
Orthofix Medical Inc. (OFIX) has a market capitalization of $373.88M as of 2026-06-30.
What exchange does OFIX trade on?
Orthofix Medical Inc. (OFIX) trades on the Nasdaq.